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Introduction In addition to inflammation of the joints, rheumatoid arthritis (RA) has a neurological part consisting of pain, fatigue, depression and cognitive deterioration. These symptoms are critical for the patients' ability to cope with daily life, but are not alleviated completely with modern antirheumatic drugs. Sufficient IGF1R signalling is important for neurogenesis in the hippocampus. Its misbalance correlates with depression and anxiety.
Objectives The aim of this study was to evaluate the pathological changes in the brain during experimental RA and investigate their connexion to IGF1R. Methods Characteristics of pain, depression and anxiety were collected among 214 RA patients and analysed in relation to IGF1R expression in WBC. Experimental RA was induced by immunisation with collagen II. Inhibition of IGF1R was achieved by injection of shRNA-producing lentiviral construct. The behavioural pattern of each mouse was recorded by filming. The hippocampus was analysed morphometrically, and gene and protein expression were analysed by qPCR and immunohistochemistry, respectively. Results The RA patients' perception of depression and anxiety was associated with high IGF1R expression in WBC. This group of patients was also less physically active. In experimental RA, an enrichment of IBA1 +microglia and high expression of CD68 and IL-1b was found in the hippocampus. This was followed by an increased density of IGF1R+cells in cornu ammoni, and a decreased neurogenesis by limited expression DCX in the subgranular layer of the dentate gyrus. This results in a significant reduction of the hippocampus area. These changes in the brain were associated with immobility in RA mice. Treatment with shRNA targeting IGF1R improved arthritis, but led to increased immobility. Conclusions RA induces remote inflammation in the hippocampus reducing neurogenesis and physical activity. The neurological symptoms in patients and in experimental RA are connected to IGF1R expression and signalling, and further expands our knowledge of neurological processes in RA. Introduction Autoantibodies to citrullinated proteins (ACPA) are specifically associated to rheumatoid arthritis (RA) and probably involved in its pathophysiology. ACPA are produced in the inflamed synovial tissue (ST). We demonstrated that peptidylarginine deiminases (PAD) 2 and 4 are present in the tissue and probably responsible for fibrin citrullination, and consequently for genesis of the epitopes targeted by ACPA. PAD2 and 4 are expressed in the intima and the subintimal inflammatory infiltrates, essentially by CD68 +mononuclear cells. 1 We suspected macrophages (MF) of the ST to be responsible for synthesis and release of PADs in the interstitium, inducing citrullination of the local fibrin deposits. We generated in vitro various subsets of MF in the presence of IFN-g, IL-4, IL-10 or M-CSF, and observed a major influence of the phenotype of polarised MF on cytokine response to ACPA-containing immune complexes.
